Home Newsfeeds HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

HC Wainwright & Co. analyst Ed Arce maintains Terns Pharma (NASDAQ:TERN) with a Neutral and raises the price target from $6 to $7.

byBenzinga Newsdesk

December 29, 2022

1 minute read

HC Wainwright & Co. analyst Ed Arce maintains Terns Pharma (NASDAQ:TERN) with a Neutral and raises the price target from $6 to $7.

$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying

By Avi Kapoor

June 3, 8:33 AM

Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades. When insiders purchase…

APPN

Guggenheim Maintains Buy on VF, Lowers Price Target to $50

By Benzinga Newsdesk

September 30, 9:54 AM

Guggenheim analyst Robert Drbul maintains VF (NYSE:VFC) with a Buy and lowers the price target from $60 to $50.

VFC

Red White & Bloom To Acquire Beleaguered Canadian Cannabis Operator Aleafia

By Maureen Meehan

June 7, 7:59 PM

Red White & Bloom Brands Inc. (OTCEM: RWBYF) and Aleafia Health Inc. (OTCQB: ALEAF) have entered into a binding letter agreement whereby Red White & Bloom (RWB) will acquire Aleafia and its subsidiaries in a share-exchange agreement.

ALEAF

RBC Capital Reiterates Outperform on Uber Technologies, Maintains $46 Price Target

By Benzinga Newsdesk

February 9, 10:22 AM

RBC Capital analyst Brad Erickson reiterates Uber Technologies (NYSE:UBER) with a Outperform and maintains $46 price target.

UBER

HC Wainwright & Co. Maintains Neutral on Terns Pharma, Raises Price Target to $7

Related Posts

$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying

Guggenheim Maintains Buy on VF, Lowers Price Target to $50

Red White & Bloom To Acquire Beleaguered Canadian Cannabis Operator Aleafia

RBC Capital Reiterates Outperform on Uber Technologies, Maintains $46 Price Target